Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.05
(1.01%)
CNY 13.05
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.3 Billion | 17.43 Billion | 14.58 Billion | 12.65 Billion | 10.47 Billion | 9.17 Billion |
| Cost of Revenue | 11.75 Billion | 11.32 Billion | 9.19 Billion | 8.12 Billion | 6.42 Billion | 5.45 Billion |
| Gross Profit | 5.55 Billion | 6.1 Billion | 5.39 Billion | 4.53 Billion | 4.05 Billion | 3.71 Billion |
| Operating Expenses | 4.78 Billion | 4.49 Billion | 4.09 Billion | 3.55 Billion | 3.25 Billion | 2.92 Billion |
| Selling, General and Administrative Expenses | 4.68 Billion | 4.13 Billion | 3.76 Billion | 3.12 Billion | 2.9 Billion | 2.5 Billion |
| Research and Development Expenses | 10.2 Million | 8.74 Million | 5.39 Million | 839.48 Thousand | 238.51 Thousand | 146.38 Thousand |
| Other Expenses | 90.11 Million | 349.12 Million | 320.56 Million | 437.64 Million | 343.32 Million | 414.34 Million |
| Cost and Expenses | 16.59 Billion | 15.81 Billion | 13.28 Billion | 11.68 Billion | 9.67 Billion | 8.38 Billion |
| Operating Income | 786.44 Million | 1.66 Billion | 1.06 Billion | 917.92 Million | 739.21 Million | 684.32 Million |
| Interest Expense | 135.33 Million | 147.12 Million | 136.22 Million | 24.54 Million | 33.71 Million | 47.6 Million |
| Income Tax Expense | 142.15 Million | 222 Million | 179.31 Million | 167.72 Million | 145.73 Million | 171.9 Million |
| Earnings before Tax | 702.56 Million | 1.23 Billion | 1.09 Billion | 956.89 Million | 749.05 Million | 691.67 Million |
| Net Income | 549.44 Million | 1 Billion | 921.58 Million | 789.96 Million | 603.91 Million | 521.06 Million |
| Earnings Per Share Basic | 0.92 | 1.70 | 1.56 | 1.38 | 1.06 | 0.92 |
| Earnings Per Share Diluted | 0.92 | 1.70 | 1.56 | 1.38 | 1.06 | 0.92 |
| Weighted Average Shares Outstanding | 596.82 Million | 593.34 Million | 590.19 Million | 572.31 Million | 567.77 Million | 567.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 596.82 Million | 595.23 Million | 592.27 Million | 573.22 Million | 568.23 Million | 567.79 Million |
| Gross Margin | 0.32 | 0.35 | 0.37 | 0.36 | 0.39 | 0.41 |
| EBIT Margin | 0.13 | 0.15 | 0.17 | 0.09 | 0.09 | 0.10 |
| Profit Margin | 0.03 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| EBITDA | 2.18 Billion | 2.53 Billion | 2.44 Billion | 1.07 Billion | 856.18 Million | 813.63 Million |
| Earnings Before Tax Margin | 0.05 | 0.10 | 0.07 | 0.07 | 0.07 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 4.26 Billion | 4.19 Billion | 5.08 Billion | 4.52 Billion | 17.3 Billion | 4.13 Billion |
| Cost of Revenue | 2.89 Billion | 2.85 Billion | 3.55 Billion | 3.1 Billion | 11.75 Billion | 2.8 Billion |
| Gross Profit | 1.36 Billion | 1.33 Billion | 1.53 Billion | 1.41 Billion | 5.55 Billion | 1.33 Billion |
| Operating Expenses | 1.3 Billion | 1.26 Billion | 1.24 Billion | 1.41 Billion | 4.71 Billion | 1.07 Billion |
| Selling, General and Administrative Expenses | 1.27 Billion | 1.21 Billion | 1.2 Billion | 1.35 Billion | - | 1.25 Billion |
| Research and Development Expenses | 2.41 Million | 2.74 Million | 2.83 Million | 2.55 Million | - | 3.15 Million |
| Other Expenses | -31.82 Million | -41.6 Million | -31.51 Million | -58.31 Million | -106.57 Million | -2.33 Million |
| Cost and Expenses | 4.2 Billion | 4.11 Billion | 4.79 Billion | 4.52 Billion | 16.46 Billion | 3.87 Billion |
| Operating Income | 58.68 Million | 74.69 Million | 296.33 Million | 1.4 Million | 833.53 Million | 215.79 Million |
| Interest Expense | 37.02 Million | 36.53 Million | 35.7 Million | 40.72 Million | 135.33 Million | 35.67 Million |
| Income Tax Expense | 12.32 Million | 9.65 Million | 39.31 Million | 51.22 Million | 142.15 Million | 29.6 Million |
| Earnings before Tax | 28.37 Million | 59.07 Million | 286.26 Million | -79.95 Million | 709.9 Million | 213.45 Million |
| Net Income | 10.59 Million | 39.98 Million | 241.91 Million | -136.47 Million | 549.44 Million | 181.34 Million |
| Earnings Per Share Basic | 0.02 | 0.07 | 0.41 | -0.23 | - | 0.30 |
| Earnings Per Share Diluted | 0.02 | 0.07 | 0.41 | -0.23 | - | 0.30 |
| Weighted Average Shares Outstanding | 595.45 Million | 596 Million | 596 Million | 595.77 Million | 595.77 Million | 595.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 595.45 Million | 596 Million | 596 Million | 595.77 Million | 596.82 Million | 595.77 Million |
| Gross Margin | 0.32 | 0.32 | 0.30 | 0.31 | 0.32 | 0.32 |
| EBIT Margin | 0.02 | 0.10 | 0.07 | 0.08 | - | 0.07 |
| Profit Margin | 0.00 | 0.01 | 0.05 | -0.03 | 0.03 | 0.04 |
| EBITDA | 65.4 Million | 404.86 Million | 373.47 Million | 342.71 Million | - | 272.14 Million |
| Earnings Before Tax Margin | 0.01 | 0.02 | 0.06 | 0.00 | 0.05 | 0.05 |
600109
TEMN
603596
AVH
600880
0JQR